News

Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

January 04, 2021

REDWOOD CITY, Calif. , Jan. 04, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome

December 11, 2020

Soleno intends to submit plans to FDA to conduct further analyses of clinical data from ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results

November 10, 2020

REDWOOD CITY, Calif. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More
Soleno – Home